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Depending on external conditions, native proteins may change their structure and undergo
different association routes leading to a large scale polymorphism of the aggregates. This feature
has been widely observed but is not fully understood yet. This review focuses on morphologies,
physico-chemical properties andmechanisms of formation of amyloid structures and protein super-
structures. In particular, the main focus will be on protein particulates and amyloid-like spherulites,
brieﬂy summarizing possible experimental methods of analysis. Moreover, we will highlight the role
of protein conformational changes and dominant forces in driving association together with their
connection with the ﬁnal aggregate structure. Eventually, we will discuss future perspectives in this
ﬁeld and we will comment what is, in our opinion, urgently needed.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. The complexity of protein aggregation phenomena
The theme of protein aggregation can be certainly considered as
one of the most appealing and challenging of current scientiﬁc
research. Such phenomena are of fundamental interest in both
basic and applied sciences. Nowadays a large number of
pathologies are deﬁned as ‘‘conformational diseases’’ since their
origin is attributed to changes in shape and conformation of
speciﬁc proteins with consequent destabilization, association and
tissue-deposition. Among them, Alzheimer’s and Parkinson’s dis-
eases together with diabetes mellitus type II are considered to be
the largest health care challenge of the century [1]. Investigating
the origin of these pathologies cannot be separated from an accu-
rate description of the inter- and intra-molecular interactions
involved in the formation and deposition of protein aggregates.
Deposits of supramolecular aggregates, which often present them-
selves as ordered ﬁbrils called amyloid, are associated with many
neurological pathologies [2–4]. Amyloid ﬁbrils are characterized
by a common cross-b-sheet structure and they can present
different isoforms potentially leading to different biological effects
[5–7]. During amyloid formation a continuum of aggregated species
is formed and, depending on protein sequence and externalconditions, different intermediate states are generated with
different structure and speciﬁcity, which in turn regulate the kinet-
ics and the appearance of the ﬁnal aggregates. Intermediate states
and oligomers (either soluble or insoluble) are recognized to be key
effectors of toxicity [6–10]. These species have been found to share
both common structural features and the ability to permeabilise
cell membranes, potentially initiating multiple processes leading
to cell impairment and death [7–9].
Beside its clinical implications, protein aggregate formation
presents a great potential in drug discovery and formulation [10]
and it is involved in functional roles in many living species [11].
Moreover, the intrinsic and tunable diversity of protein aggregates
either of ﬁbrils or more complex superstructures [12–14], and
their physico-chemical and extraordinary mechanical properties
[15–17] give a wide range of opportunities for the design of new
nanomaterials [18,19]. The origin of these properties appears to
be related to the way protein molecules interact when forming
amyloid aggregates, i.e. the structural hierarchy, protoﬁlament
packing and ﬁbril length and thickness. Structural properties rule
structural ﬂexibility, surface topology and the distribution of
hydrophobic regions on the surface of amyloids, thus affecting
their interaction with the environment and, as a consequence, their
biological function [4,7,11,12,14].
Protein aggregation is concerned with many-body transition
between an initial (soluble precursors) and a ﬁnal phase (insoluble
Table 1
Nomenclature for different aggregate structures.
Amorphous
aggregate
Protein supramolecular assembly without deﬁned
shape or structure, often the result of disordered non-
speciﬁc interactions.
Fibrillar aggregate/
amyloid ﬁbril
Protein aggregate, b-sheet rich, with elongated
morphology (about 10 nm in diameter and lengths up
to several micrometers). Thermodynamically stable
and ordered structure stabilized by a common cross-b
secondary structure. Distinct observable features are:
the characteristic X-ray ﬁber diffraction pattern, b-
sheet rich CD and FTIR spectra with pronounced
shoulder around 1620 cm1 and binding to
Thioﬂavin-T or Congo red dyes [1,5,51–55].
Oligomers Small globular (spherical, chain-like or annular)
aggregate (less than 50 nm) formed by a small
number of partially unfolded units (usually less than
50). Highly reactive species, may be either a
metastable intermediate on pathway to ﬁbril
formation or an off pathway product of aggregation.
Protoﬁbrils Small thin ﬁlamentous structure with a high b-
aggregate structure content. It may be precursor to
full-length ﬁbril representing an intermediate
structure during amyloid ﬁbril formation.
Superstructure Generic mesoscopic assembly that can have either
amyloid-like features or not. Superstructures can be
formed by non-ordered clustering of single amyloid-
like ﬁlaments or having peculiar geometry and
physico-chemical properties.
Amyloid-like
spherulite
Spherical amyloid-like superstructure characterized
by a dense core and a low-density corona. They
present a Maltese cross pattern under cross-polarized
optical microscopy [43,44,50]. Characteristic radius is
in the range of few lm up to mm. They are formed
in vitro at high temperature and in solution having pH
far from the pI of the protein (generally acidic pH).
Protein particulates Spherical superstructure with a characteristic radius
in the range of few hundreds of nm up to 2 lm. They
are formed in vitro at high temperature and in
solution having pH close to the pI of the protein
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inter-molecular interactions modulated by initial protein structure
and dynamics, and physico-chemical properties of the environ-
ment. Depending on the equilibria between associative mecha-
nisms, different structures other than amyloid ﬁbrils can be
formed [12,14,20].
Large efforts of the scientiﬁc community are addressed to the
characterization of amyloid aggregation. Several models for the
mechanism of amyloid formation have been proposed [21]. They
are mainly based on nucleation and growth mechanisms (primary
and secondary pathways) [22–27] including initial micelle
formation [28], changes in protein conformation [29,30] and
ﬁlament–ﬁlament association [31]. Moreover, some proteins seem
to assemble through entirely non-nucleated processes [32].
A number of evidences revealed that amyloid structures are
capable of substantial conformational changes that can be
observed even within individual ﬁbrils. Speciﬁcally, the side chain
spacing was shown to vary signiﬁcantly for different amyloid
ﬁbrils [33]. This multiplicity of forms concerns structurally distin-
guishable isoforms of amyloid ﬁbrils where the difference in struc-
tures occurs at the level of inter or intra-residual interactions
(microscopic polymorphism or conformational polymorphism) and
can lead, for example, to different (ﬁbril) structural variants with
different chiroptical properties [34,35] Such polymorphism has
been observed both in vitro and in vivo. In the latter case, struc-
turally different ﬁbrils or ensembles of ﬁbril morphologies are
thought to underlie different biological activities, such as different
toxicities to neuronal cells [36] or deposition patterns in speciﬁc
diseases [37]. Moreover, different mechanical properties are asso-
ciated to different ﬁbril morphologies. This may be due to the
structural arrangement at molecular level but also to different
interactions with the environment. Within aggregates, changes in
the exposure of protein surface to hydration water may alter both
dynamics and mechanics of amyloid ﬁbrils [38,39] and of hydra-
tion water [40] with respect to native states [41]. Depending on
the morphology, the softness of the protein polypeptide chain
changes due both to the distribution of vibrational modes and
the dissipative mechanisms of collective low-frequency vibrations
provided by water-protein and protein–protein interactions [38].
Interestingly, a number of studies recently reported the possi-
bility of a variety of large scale arrangements of amyloid aggregate:
protein molecules may not necessarily self-assemble in single
elongated ﬁbril-like structure, but the ﬁbrils may generally con-
serve their basic structural arrangement of cross b-sheet, yet expe-
rience different packing into three dimensional well deﬁned
superstructures (macroscopic polymorphism) [42,45]. Such a poly-
morphism concerns large scale arrangements of generic amyloid
aggregates with characteristic sizes in the range of several lm
and it is signiﬁcantly different from the conformational polymor-
phism (of amyloid ﬁbrils) mentioned above. Several different large
scale amyloid morphologies have been reported in the past (e.g.
[42–46]). It is also possible that the speciﬁc 3D structural arrange-
ment is entirely determined by the physico-chemical properties of
the solvent. Speciﬁcally, it has been reported that the charge of the
protein molecule (i.e. pH of the solution) is crucial in determining
the ﬁnal large scale arrangement [20,47–49]. For several globular
proteins as, among others, insulin, beta-lactoglobulin, lysozyme,
under destabilizing conditions and close to the isoelectric point
(pI) of the protein, compact spherical aggregates with radius up
to 1–2 lm are detected (particulate) [48]. On the other hand at
low pH far from the pI, elongated amyloid ﬁbrils [24] occur
together with a fascinating morphology known in the literature
as an amyloid spherulite [43,44,50]. All this points towards a depen-
dence of the ﬁnal structures on the overall net charge of the single
protein molecule. Notwithstanding the above mentioned large
scale polymorphism has been widely observed, a deep knowledgeof the molecular origin is still out of reach, including how the early
protein–protein interactions can determine the speciﬁc
arrangements.
The above mentioned diversity of mechanisms leading to the
wide range of ﬁnal and intermediate aggregates often results in a
misleading use of nomenclature and deﬁnitions in literature. For
this reason we report in Table 1 the terms we will use in the review
and what they refer to.
In this work, we focus on the mechanisms by which an initially
fully folded globular protein undergoes aggregation; different
aggregation pathways may lead to the formation of amyloid ﬁbrils,
amorphous aggregates and superstructures depending both on
protein structure and solution conditions. We will not discuss
the aggregation process in terms of nucleation-elongation models.
We will rather focus on approaches to monitor the early structural
changes in terms of conformational changes and how an ensemble
of protein can be converted in 3D macroscopic superstructures,
namely amyloid-like spherulites and particulates. We address the
reader to the huge body of literature about nucleation model
(see [4,21,27] and references therein) and structural characteriza-
tion of elongated ﬁbrils (e.g. [33]). These topics will be not dis-
cussed here.
2. Generalized protein energy landscape and dominant forces in
protein aggregation
Aggregation implies a number of different mechanisms, such as
conformational changes (possibly including oligomerization) and
formation of intermolecular bonds (involving single residues,
speciﬁc regions or the whole molecule), nucleation mechanisms,
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aggregates [21,55–59]. The above mechanisms involve multiple
interactions arising from both direct and solvent-induced forces,
which are equally effective at inter and intra-molecular level. All
these mechanisms are reasonably interconnected, and their occur-
rence and extent are regulated by external conditions. In this
respect, aggregation involves proteins both on a microscopic scale
(structural and conformational changes on single molecules), and
on a macroscopic scale (interactions between a large number of
molecules, e.g. gelation), bringing to a variety of different processes
and of different supramolecular structures [60–62]. In such intri-
cate scenario, both experimental and computational studies sug-
gest the existence of general physical principles which govern
protein aggregation and supramolecular structure formation
[63–65].
The protein searches for a set of critical contacts unify the
description of protein folding and aggregation. Indeed, a number
of evidences shows that proteins sacriﬁce contacts in their native
state, favoring intermolecular contacts with neighboring proteins.
In this situation, aggregated states result thermodynamically sim-
ilar or more favorable than the native state. It is well established
that there is a kinetic partitioning of protein folding and aggrega-
tion [66–68]. These two phenomena involve the development of
inter-residue interactions of essentially identical character.
Although protein folding is an efﬁcient process and partially folded
states, which are prone to aggregation, are only transiently formed,
alterations in environmental conditions or mutations can dramat-
ically affect the energy landscape. These can convert the protein
from a kinetically favored native and functional state to a globally
more stable aggregate structure [68–70].
The stability of a protein and its folding/unfolding pathway can
be described by means of a funnel-like free energy landscape [71]
which describes from a statistical point of view the free energy of
the polypeptide chain as a function of its conformational proper-
ties. The surface of this folding funnel is unique for a speciﬁc
polypeptide sequence under a given set of conditions and it is
determined by both thermodynamic and kinetic properties of the
folding polypeptide chain [59,71–73]. Each point on this surface
describes a speciﬁc conformational state of the protein. The shape
of the energy landscape is affected by the contribution of enthalpic
terms due to aminoacids’ interactions and to both enthalpic and
entropic terms related to the interaction with the environment.
The energy landscape perspective can be extended to a
protein-solvent system; in this more general case, each point on
the surface corresponds to a given conformation of the overall sys-
tem, including both intra-molecular, inter-molecular, and solvent
conﬁgurations [67,68,73]. Minima in this space represent mechan-
ically stable molecular states, such as oligomers, amorphous or
ordered aggregates. A deep and sharp minimum on the
multiple-protein surface is assigned to amyloid ﬁbrils, which rep-
resent the most stable state that proteins can adopt [70,74].
Protein aggregation can be seen as the result of a thermody-
namic drive, dependent on the particular conditions, towards a
lower free energy state of the overall system, i.e. protein molecules
and solvent. This may happen via protein conformational changes,
causing a change of solute–solvent free energy of interaction
and/or via an appropriate loss of the overall homogeneity of the
solution. In terms of free energy of the whole solution, the interac-
tions with and via solvent must be taken into account [75,76]. The
driving forces toward the equilibrium state are both ‘‘non-speciﬁc’’
(e.g. hydrophobic and electrostatic) and speciﬁc (e.g. salt-bridging
between residues) [77] and are common both to folding and aggre-
gation. As a consequence, aggregation process can be considered as
acting in competition with the normal folding pathway [59,64,66–
69]. Amyloid aggregation seems to occur only when substantial
structural reorganizations allow the formation of a favorablestructure: the cross-b sheet. This structure imposes essentially
one-dimensional aggregation and it is general for all amyloid
ﬁbrils.
A common experimental observation is the link between the
self-aggregation process and hydrophobic interactions which are
of great importance in maintaining the structural integrity of pro-
teins but can also be considered driving forces in aggregation. The
aggregation process involves delicate balances of hydrophobic
interactions and increasing polar interactions (i.e. H-bonds) in
and between molecules leading to the formation of ordered ﬁbrils.
While hydrophobic interactions contribute to the intermolecular
association of the intermediate structures through side-chain
interactions, polar interactions essentially contribute to the inter-
molecular hydrogen bonds stabilizing the cross-b-structure [78].
In this respect, it is important to note that hydrogen bonds are
strengthened in a hydrophobic environment [79] and that
inter-chain H-bonds are considered to be energetically favorable
with respect to the hydrogen bonds with water, even if they
require an increase of entropy to arrange such bonds in ordered
structures [63–80].
A fundamental role in regulating aggregate structures is also
played by electrostatic interactions as suggested by the strong
dependence of supramolecular assembly processes on pH and
salt concentration. Electrostatic interactions may be long range,
directionless, non-speciﬁc coulombic interactions, or short range
electrostatic forces like salt bridges. These last ones can also
affect protein stability through ion pairing [77,81,82]. It should
be noted that in general charged groups are far from being
evenly distributed; they are rather grouped in ‘patches’ generat-
ing a complex mosaic on the protein surface. This means that
electric dipole and higher multipole moments may be large, so
that their effects on inter-particle interactions may be rather
strong. Under conditions which destabilize native state, protein
charge modulates the rates and forms of aggregation: far from
the isoelectric point, partially unfolded states are highly charged,
thus resulting in long-range repulsion and slow aggregation
[47–49,58,75,83]. Moreover, recent results by site-directed
thermodynamics give new insight on the interplay between
hydrophobic and electrostatic interaction [84]. For example, it
was shown that when the protein total charge is negative, the
solubility of the protein in principle increases (decreases) if a
neutral amino acid is mutated to a negatively (positively)
charged one [84]. This ﬁnding has signiﬁcant implications in
controlling protein aggregation propensity through site-directed
mutagenesis. Experimental results have indicated that amyloid
aggregation occurs under conditions in which the net charge of
protein molecules is diminished i.e. when protein association is
favored [85] but also in conditions that increase protein net
charge, this being conﬁrmed by several experimental and theo-
retical works [13,20,47,49,86]. In this respect, it should be noted
that the increase of molecules net charge at pH far from the
isoelectric point may decrease the intrinsic aggregation propen-
sity but it also produces protein destabilization, thus allowing
the protein to adopt an ensemble of fully or partially unfolded
conformations that are highly prone to aggregation [30,77].
Moreover, further effects can take place depending also on the
speciﬁcity of the ions [87].
These apparently controversial results could be rationalized in
the complex landscape of aggregation also in view of protein speci-
ﬁcity: sequence properties such us hydrophobicity, the presence of
abundant aromatic residues and b-sheet propensity can also play
an important role in the amyloidogenecity of polypeptides (see
eg. [88,89]). Finally, ﬂexibility of protein molecules, inﬂuenced by
the interplay between hydrophobic interactions and charge, has
to be considered as general property affecting protein aggregation
(see eg. [86,87]).
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Aggregation canbe promotedby thepreferential solvent exposure
and/or ﬂexibility of speciﬁc protein regions and also by disordered
interactions. An ensemble of proteins may form aggregated struc-
tures inwhich the individual proteinmolecules retain characteristics
that are still reminiscent of the native state or theymay undergo crit-
ical changes leading to the common amyloidal structures. Partially
unfolded conformations, ﬂexible enough to transiently expose back-
bone amides to hydrogen exchange with the solvent, may constitute
aggregation-prone reactive species. Irrespective of theﬁnal aggregate
features, aggregation is characterized by the occurrence of some kind
of conformational/structural changes which transform native pro-
teins into ‘‘sticky’’ reactive species. These changes can take place as
preliminary, concomitant or ﬁnal step during the massive aggrega-
tionprocess [2,6,30,59,83,86,90]. The formationof amyloid structures
involves intermolecular hydrogen bonding of polypeptide strands,
whose formation in turn has to causemodiﬁcations in native confor-
mation. At molecular structure level, intrinsic protein ﬂexibility
makes possible conformational changes, which are the result of
changes in main-chain torsional angles and side chain orientations
and may occur with only relatively small costs in terms of energy.
The overall effect of such changes may cause the re-orientation of
few residues; in particular changes localized in critical regions may
lead to reorganization of the whole protein structure.
Protein conformational changes could determine a partial expo-
sure of reactive non-polar groups buried inside the native struc-
ture, giving rise to new intermolecular interactions which are
absent in the normally folded state. From a thermodynamic point
of view, these variations may modify some regions of the energy
landscape, by changing protein-solvent interactions and in turn
changing the region of thermodynamic stability. A further possible
scenario is that variations in the external conditions could perturb
the single protein equilibrium vs aggregated structures not
depending on the native structure variations and, therefore, give
rise to aggregate formation. This is conﬁrmed by several studies
showing that in some cases aggregation can be initiated from
highly native-like states before major conformational rearrange-
ments [91,92]. In this context, conformational changes would
occur after aggregate formation due to changes in protein sur-
roundings. So, the formation of ‘‘aggregate states’’ could in turn
favor the conformational change, leading to a greater exposure of
hydrophobic groups. In such a way, a feedback mechanism able
to promote self-trapping processes in deeper and deeper free
energy minima of the entire protein-solvent system is created
[6,67,86]. This mechanism is often observable via seeding a protein
solution with preformed ﬁbrils [93]. This procedure can dramati-
cally enhance the growth rate of amyloid aggregate. Beside the
possibility of catalyzing the assembly reaction (via secondary
nucleation mechanisms), seeds may act as a template for inducing
conformational changes in surrounding proteins and tune the mor-
phology of the resulting aggregates [94].
Importantly, even small differences in occurring conformational
changes may alter the nature of protein–protein interactions
inhibiting or promoting amyloid ﬁbril formation. Such differences
may change the nature of interacting surfaces and in turn the stabil-
ity of intermediate states, resulting in ﬁnal amyloid specieswith dif-
ferent nature [60,61,95]. Intriguingly, different conformational and
structural changes occurring along the reaction are related to differ-
ent morphologies of amyloid ﬁbrils formed from the same protein.
They regulate both the ﬁbril biological activity, toxicity [6–8,36]
and physicochemical and mechanical properties [16,17,38,90,91]
Even subtle modiﬁcations at single residue level in protein
structures may alter speciﬁc inter-protein and protein-solvent
interactions. For example in an energy landscape perspective, theoxidation of a single amino acid may change the energy funnel of
the non-oxidized protein, both in terms of roughness and the ratio
between differentminima.Moreover, oxidation or other pointmod-
iﬁcations can also modify the energy potential surface leading to
new and more stable minima. All this leads to changes in both the
aggregation propensity and/or pathways (e.g. [92]).
It is worth mentioning how conformational changes are consid-
ered in the framework of the nucleation-dependentmodels, the lat-
ter often reported to be at the basis of the growth of amyloid
aggregates. According to these models, protein monomers convert
into ﬁbrillar structure via transiently populated aggregation nuclei
in which a high-energy oligomer (the nucleus) acts as a bottleneck
that limits the rate of ﬁbril formation (primary nucleation); after-
wards, elongation and thickening proceed by addition of monomers
or oligomers and further associations of already formed ﬁbrils or via
secondary nucleationmechanisms as branching, fragmentation and
nucleation at the surface of already formed ﬁbrils in solution
[21,25–30,97]. The assembly pathway may involve conformational
changes before, over and above classic nucleation-dependent
mechanisms. Conformational transitions within the lag-phase have
been reported for several proteins. Cystatin forms a tetramer prior
to amyloidogenesis [98]; insulin ﬁbril formation involves the disso-
ciation of native associated states [24]; transthyretin tetramer ﬁrst
dissociates into native monomers and, subsequently, these species
partially unfold to form intermediate structures which ﬁnally
polymerize in ﬁbrillar structures [99]. Moreover, in such diversiﬁed
scenarios of mechanisms, a multitude of morphologies can be
simultaneously formed. As a consequence, while the nucleation-
based models and theory can be general and take into account for
the massive growth of the aggregates, a more detailed and speciﬁc
analysis needs to be performed in parallel to highlight the extent
and the occurrence of the conformational changes, being such anal-
ysis strongly dependent on the protein and the experimental condi-
tions under investigation. A generalization in terms of kinetics
scaling laws as for the nucleation model is difﬁcult to be proposed
for the conformational changes and ad hoc and unique design of
experiments is crucial for each protein system.
4. Assembly into complex superstructures: amyloid-like
spherulites and particulates
As mentioned before, amyloid-like ﬁbrils represent only one of
the several different species occurring during an aggregation pro-
cess and most of the literature in the ﬁeld is focused on highlight-
ing this. In the following sections, we will present two speciﬁc
ﬁnal structures, namely amyloid-like spherulites and protein par-
ticulates, falling in the category of the so-called superstructures.
The choice of focusing on such species is dictated by the fact that
(1) such species are formed in peculiar conditions for a number of
globular proteins and intrinsically disordered proteins, (2) the
tunability of both their sizes and morphology makes them good
candidate for application as biomaterials and (3) the existence
of such species should always be considered in any attempt of
modeling the aggregation kinetics. Importantly, the reader should
consider that the appearance of less ordered and less deﬁned
superstructures or with very peculiar chiroptical properties can
also take place as a ﬁnal result of an aggregation process.
However, these species will not be considered in the present
work and we address the reader to more speciﬁc literature (e.g.
[34,35,42]).
4.1. Particulates
Protein particulates have been shown in vitro for a series of pro-
teins and peptides not necessarily sharing structural homology.
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and only at the isoelectric point of the protein, i.e. very low or no
net charge on the protein molecule. Speciﬁcally, particulate was
observed in bovine beta-lactoglobulin, bovine serum albumin,
bovine insulin, horse heart myoglobin, hen eggwhite lysozyme,
human transthyretin, human-synuclein [48], and recently in
equine lysozyme [100]. Particulate is a spherical assembly of pro-
teins with a radius in the range of hundreds of nm up to few
micrometers (Fig. 1a–c).
They have a very dense structure that is barely affected by
change in its hydration state and they also present a noticeable
resistance against sonication. Importantly, there are no evidence
for the particulate to be formed by speciﬁc packing of amyloid ﬁb-
rils. The process bringing an ensemble of proteins to self-assemble
in particulate has been studied in details for beta-lactoglobulin.
Using ESEM, particle sizes were found to depend on the heating
regime (both temperature value and rate) used for their formation,
leading to a nearly monodisperse distribution of particle sizes dur-
ing isothermal experiments. Moreover, particulates exhibit sec-
ondary structure rather similar to the protein’s native state. This
is in contrast to amyloid ﬁbrils and to spherulites, where the sec-
ondary structure is rich in beta structures, regardless of the protein
contained within them [44]. The lack of common secondary struc-
ture in the particulate suggests, therefore, that the protein is only
partially unfolded before aggregation and that no or only minor
reorganization occurs before, during, or after aggregation into the
particulate [48]. Such initial observations were then conﬁrmed
by a recent work of particulate formation in equine lysozyme sam-
ples [100]. Speciﬁcally, the early structural changes are rather lim-
ited but sufﬁcient to shift the equilibrium of the equine lysozyme
solution towards a molten globule-like state from which particu-
late originates. Using two-photon excitation ﬂuorescence micro-
scopy and X-ray diffraction, the study also shows the signiﬁcant
hydrophobicity of the inner part of the structures, a strong
ThT-positive signal and a isotropic arrangement of beta sheet
structure (Fig. 1d and e). Speciﬁcally, the hydrophobic dye ANS
(cyan in Fig. 1a) is able to stain the interior part of the aggregates
that is instead not accessible by the hydrophilic dye Alexa (red inFig. 1. Left: two-photon excitation ﬂuorescence microscopy and X-ray diffraction data o
conﬁguration; (b) Alexa and (c) ANS, both in a single color, showing that the interior of
particulates. Right: insulin Amylod-like Spherulites detected by (f) cross-polarized micr
Environmental Scanning Electron Microscopy. (i) Magniﬁcation of panel (h) showing the i
papers (Refs. [100,102]).Fig. 1b). Thioﬂavin T shows a uniform green ﬂuorescence in all
the aggregate volume. Interestingly, the X-ray diffraction pattern
resembles the peculiar distances detected for amyloid-like ﬁbrils.
However, in the case of particulate, the isotropic rings (Fig. 1e)
stem from a distribution of beta-sheet with no speciﬁc alignment,
being this in agreement with the spherical symmetry of this super-
structure. All these evidences pose new questions about the nature
of this structure that even if not showing a clear amyloid-like nat-
ure should not simply be considered amorphous. Recently, using a
statistical mechanical approach, the formation of such micrometric
dense spherical structures was modeled and the results show how
the spherical symmetry takes only place when the net charge on
the single protein molecules is not signiﬁcant, conﬁrming that
the electrostatic interactions control the ﬁnal morphology [20].
4.2. Amyloid-like spherulites
Spherulites are most commonly associated with synthetic poly-
mers. Characteristic of spherulites are the regular arrangement of
polymer chains within them, resulting in the appearance of a
Maltese cross extinction pattern when the spherulites are studied
under a polarized light microscope. The seminal work showing
the ability of a full-length protein to form such micrometric struc-
ture was reported in 2004 for insulin [43]. Since then, further stud-
ies have been performed on insulin [12,44,45,50,101,102] and
several even structurally unrelated proteins and peptides have
been shown to have the same ability of forming in vitro spherulites
in speciﬁc experimental conditions: A-beta (1–42) [103],
beta-lactoglobulin [104], myelin basic protein (MBP) [105], a
hexapeptide of human calcitonin [106], recombinant human inter-
feron alpha-2b [107], pro-islet amyloid polypeptide ProIAPP(1–48)
[108], whey protein mixtures [109] and Human Serum Albumin
[110]. Moreover, beta-sheet rich spherulites were observed in
human brain tissues, resembling senile plaques associated with
Alzheimer’s disease [111], highlighting the potential involvement
of such structures in the pathology. It is generally accepted that
amyloid-like spherulites are formed by a central densely packed
part (referred as precursor) and an external shell composed byf equine lysozyme particulates. (a) ANS (cyan) and Alexa (red) staining in two-color
the aggregates is devoid of water. (d) ThT staining. (e) X-ray diffraction pattern of
oscopy, (g) two-photon excitation ﬂuorescence microscopy stained by ThT and (h)
nternal part of the spherulite. Figures are adapted with permission from the original
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the peculiar signature for protein spherulites is represented by the
Maltese cross-section when they are observed under
cross-polarized light microscope. An example of this is presented
in Fig. 1f. Such pattern shows a rather high order of the outer shell
composed by protein ﬁlaments pointing outwards (high intensity),
while the ‘‘disordered’’ central part result in dark areas in the
image (Fig. 1f). However, it is worth noting that the appearance
of such pattern can be different depending on the speciﬁc protein.
In particular it has been noted that the ratio between the central
part and the outer shell can signiﬁcantly differ if, for example, insu-
lin and beta-lactoglobulin spherulites are compared [104]. Insights
on the structures can be gained using a variety of imaging tech-
niques. Using extrinsic probes, confocal and two photon micro-
scopy can be used to reveal the arrangement of this protein
assembly (Fig. 1g). Moreover, environmental scanning electron
microscopy (ESEM) provided not only information on the spherical
morphology of the spherulites, but also information on how the
hydration state can affect the overall structure. Speciﬁcally, when
reduced the pressure (i.e. drying the sample) spherulites tend to
break [43], highlighting the critical role on water molecules in
keeping stable such a structure. The possibility to break spherulites
using ESEM allowed also to visualize the inner part (Fig. 1h and i)
using a label-free technique. This reveals the above mentioned
alignment of protein material as also veriﬁed by confocal and
two-photon microscopy. Importantly, the conversion of an ensem-
ble of native proteins into spherulites is paralleled by a signiﬁcant
formation of beta-sheet aggregate structures [43]. This means that
the formation of spherulites, as for amyloid-like ﬁbrils, is dictated
by pronounced conformational changes at the level of secondary
structures. This leads spherulites to be positively stained by the
ﬂuorescent amyloid-sensitive dye Thioﬂavin T (ThT) with a
well-deﬁned cross b diffraction pattern and a speciﬁc infrared band
of b-sheet structures [43–45,48]. All these elements together sup-
port the amyloid-like nature of such structures.
One of the most intricate aspects related to spherulites is their
mechanism of formation. In solution with pHs far from the isoelec-
tric point, they occur simultaneously with individual ﬁbril forma-
tion, so that these two species may coexist under some
experimental conditions in vitro [45]. As a consequence, for long
time it was not clear if they generally grew independently or by
simple addition of preformed ﬁbrils to the precursor. In a previous
study, an initial random aggregation has been proposed as the
pathway for the precursor formation with a consequent ﬁbril
growth outward from it. Moreover, a growth of the central part
due to ﬁbril collapse has also been suggested [104], which raises
questions about the nature of the precursor, but still supports
the idea that spherulites grow by sequential addition of protein
molecules rather than from preformed ﬁbrils. Recently, the spher-
ulite growth in protein systems has been described in terms of
multi-fractal growth, in which the fractal dimension of the growing
aggregate decreases during the growth [20]. This brings to an ini-
tial dense spherical aggregate that then develops in a hedgehog
fashion. Such growth mainly depends on the electrical charge on
the single protein molecule that in turns determines the ratio
between the dense central part and the low-density shell. This
study highlights the connection between the early protein–protein
interactions and the ﬁnal morphology and structure on micrometer
scale, being this element crucial and of general interest especially
in the ﬁeld of controlled growth of biomaterials [20].
5. Experimental approaches
A number of spectroscopic methods can been used to follow
protein aggregation pathways in a time-resolved fashion to gaininformation on conformational changes and supramolecular
assembly. This allows dealing with a number of fundamental ques-
tions as the order and timescale of aggregated structure formation,
possibly formed transient intermediates and multiple molecular
mechanisms. Information can be extracted by the analysis of the
temporal evolution of ‘‘observables’’ related to supramolecular
assembly. For example, a chemical kinetic based approach was
proposed as a tool for connecting the measurements of macro-
scopic observables to microscopic mechanisms for Ab amyloid for-
mation e.g. primary nucleation and/or more complex autocatalytic
processes [21]. Experiments in solution allow to (1) systematically
analyze the role of biophysical and biochemical properties of
aggregating proteins and environmental factors in determining
protein conformation and aggregation kinetics, (2) quantify the
energy barriers of the occurring reactions and (3) obtaining aver-
aged information on the behavior of an ensemble of molecules.
In this context, the use of a multiplexed approach based on the par-
allel use of several techniques can be successfully applied to the
study of the aggregation processes at different levels, from the very
early events, through nucleation to the ﬁnal aggregate morphology
[47,49,60,86,95,96,112–115]. In particular, it can allow the analysis
of conformational and structural changes and interactions and
their relation to speciﬁc features of ﬁnal aggregates. The probe to
determine the kinetic proﬁle of aggregation can be selected on
the grounds of the speciﬁc aggregation phase one is interested in
(e.g., oligomer formation, protoﬁbrils elongation, ﬁbril elongation
and superstructure formation) and on the particular feature under
investigation (size of the aggregates, conformational changes,
hydrophobic regions, structural changes etc.). It is important to
put in relation the temporal sequence of microscopic events with
intrinsic characteristics of the proteins (structure stability vs exter-
nal factor, i.e. temperature, pH, protein and salt concentration
which regulate the nature of the interactions). Eventually, the
use of high resolution imaging techniques is crucial for the com-
plete understanding of observed mechanisms: modern imaging
techniques not only give direct information on the morphology
and structural properties of both intermediates and ﬁnal states at
different length scale, but can also provide the visualization in real
time of the self-organization pathways. A thorough presentation of
the range of techniques to study protein aggregation, their limita-
tions and advantages would require a dedicated review. However,
we would like to provide an overview of the most common bio-
physical techniques that can be used for monitoring speciﬁc
aspects of the aggregation process. This information is included
in Table 2.
6. Conclusions and perspectives
In the early stages of protein aggregation non-native species
interact forming reactive intermediate states that are transiently
populated. The identiﬁcation of these species in terms of structure
and conformation may be of utmost importance for the deﬁnition
and consequent control of further assembly mechanisms. Knowing
the early events is necessary from a very basic point of view to
shed new light on processes that can lead to new states of a protein
(superstructures) in its generalized energy landscape. This is sum-
marized in Fig. 2 where morphologies and mechanisms are
sketched with a special emphasis on how the morphology depends
on the net charge on the single protein molecule.
From a biomedical point of view the elucidation of different
biomolecular interactions in protein aggregation and possible
organization in superstructures is crucial for the design of strate-
gies to prevent, delay or reverse the disease [135] and for the
screening of peculiar compounds (e.g. polyfenolic molecules)
which can reduce pathological effects [136]. In this context we
Table 2
Overview of the experimental techniques that can be applied to monitor protein aggregation. Most of the listed techniques are wide spread and instrumentation readily available
in many laboratories. Figures are adapted with permission from the original papers (Refs. [46,83,86,97,112–114,117,126,131]).
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Fig. 2. Scheme representing the interplay between possible interactions and mechanisms during a protein aggregation process. In speciﬁc conditions proteins undergo
conformational changes and then a massive aggregation via multiple mechanisms including nucleation mechanisms. Changes in protein structure may occur as preliminary
or intermediate step in any phase of aggregation. Their speciﬁcity regulated by environmental conditions determine the formation of different morphologies and 3D
arrangements of the ﬁnal aggregated structures. Together with the well-known elongated amyloid-like ﬁbrils, formation of mesoscopic structures as particulates and
amyloid-like spherulites can occur depending on the initial net charge on the protein molecule.
2460 V. Vetri, V. Foderà / FEBS Letters 589 (2015) 2448–2463wish to highlight that the application of advanced imaging tech-
niques may represent a tremendous advance in the comprehension
of inherent mechanisms and structures. Such techniques allow
visualizing complex multispecies reactions with non-ergodic
behavior and discriminating occurring morphologies. They offer
new and implementable capabilities in real time analysis of amy-
loid growth dynamics at the molecular level, mapping at high res-
olution various structural mechanisms involved in the initiation
and growth of different ﬁbrillar states [1,97]. Recent developments
in microscopy hardware have made possible to ‘‘readily’’ obtain
spectroscopic measurements at pixel resolution (e.g. Fluorescence,
IR, Force, Conductance spectroscopy) giving the possibility of quan-
tifying relevant parameters of the system in selected environment.
This is particularly useful since new studies on amyloid ﬁbril
formation point toward the analysis of more complex systems
(co-aggregation of different proteins, proteins with lipids and/or
other molecular species) and the possibility to reverse the aggrega-
tion kinetics. Moreover, the ambitious goal of rationalizing
protein-membrane interactions can be reached with reduced
efforts in data handling and with major reliability when micro-
scopy experiments are coupled to standard biophysical bulk
approaches. In fact, microscopy experiments allow monitoring
the self-organization pathways which involve spatially heteroge-
neous events taking membrane morphological and structural vari-
ations into account [132,134,137]. It should be also noted that
combining imaging techniques with structural approaches as
Small Angle X-ray scattering (SAXS) [100,138] and Molecular
Dynamics [139] has revealed a great potentiality in connecting
mechanisms of formation and occurring structures. Even more
ambitious is the goal of analyzing protein aggregation directly in
living cells; in this respect ﬂuorescence microscopy techniques
have shown their great potential [132,133]. These measurements
coupled with the real time analysis of cellular responses (cellviability, apoptosis, necrosis, endocytosis, membrane order) may
really provide an advance toward truly mechanistic description
of cellular processes.
It is worth noting that the connection between the physical
inter-particle interactions and the ﬁnal morphology and structure
of the self-assembled materials is also a fundamental aspect in soft
matter and material sciences. Such knowledge is pivotal for the
development and design of materials with speciﬁc physico-
chemical and geometrical properties. One of the main and notice-
able properties of spherulites and particulate is their characteristic
sizes in the range of hundreds of nm to several hundreds of
micrometers. The possibility of tuning the size is a crucial aspect
for example for biomaterials for controlled release of molecules.
As a consequence and in the light of recent reports, together with
a basic characterization of the mechanism of formation, the possi-
bility to use such protein aggregates as biomaterials should be
investigated. A ﬁrst attempt in using spherulites for sustained-
release was reported in the case of recombinant human interferon
alpha-2b [107]. However, we think that further studies in this
direction should be performed. Speciﬁcally, studies on the
bio-compatibility either as drug carrier or biomaterials for such
materials should be considered. A systematic characterization of
the physico-chemical properties (hydrophobicity, hydrophilicity,
swelling/deswelling properties) of these materials (both
spherulites and particulates) in different experimental conditions
(different proteins, co-solvents, temperature of formation, salt con-
centration, etc) would guarantee an adequate mapping and a
proper control on the ﬁnal desired structures. The possibility to
incorporate/release small molecules with different chemical nat-
ure and in different environments (solution with, e.g., different
pHs, viscosity and ionic strength) should also be considered.
Moreover, the mechanical properties of such structures should also
be investigated for potential application as scaffold biomaterials.
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